Login
Navigate Fool.com
Will PTN beat
the market?
Community Rating: 2 Stars: Unattractive

1.28 0.01 (0.79%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.29
Previous Close $1.27
Daily Range $1.25 - $1.33
52-Week Range $0.51 - $1.50
Market Cap $50.2M
P/E Ratio -8.47
Dividend (Yield) $0.00 (0.0%)
Volume 469,979
Average Daily Volume 746,597
Current FY EPS -$0.06

How do you think PTN
will perform against the market?

Top PTN Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted August 8, 2011

Another one of my long-shot micro picks that nearly doubled before nearly trapping me in a losing score due to the big plunge. Fortunately I jumped ship just in time and now I'm back in, no doubt too … More

0 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

The 10 Most-Watched Diagnostic Substances Stocks

The 10 diagnostic substances stocks our community is most interested in.

UPDATE 1-FDA hits back at charge of gender bias in libido drug decision

After-Hours Earnings Report for September 30, 2013 : PAYX, DMND, PTN

After-Hours Earnings Report for September 30, 2013 : PAYX, DMND, PTN

Trade the Earnings: Palatin Technologies Inc.

Pre-Market Earnings Report for September 11, 2012 : UNFI, AEPI, HSOL, PTN

Pre-Market Earnings Report for September 11, 2012 : UNFI, AEPI, HSOL, PTN

Palatin Tech Says AstraZeneca Halts Further Development of Obesity Drug

Setback for AZN Obesity Drug - Analyst Blog

Palatin, AstraZeneca Obesity Drug Trial Halted on Adverse Event

Palatin Tech 4Q Loss Widens Sharply As Revenue Plunges

P&G Patches Up Sex Life?

A study reveals that a testosterone patch for women can be effective.

See More PTN News...

Sector

Healthcare

Industry

Drugs

Palatin Technologies, Inc. (PTN) Description

A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics. Website: http://www.palatin.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks